Selected research
Industry Research
Life & Health Reinsurance Industry Research Report 2026
Market perspective
The global Life & Health Reinsurance market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Life & Health Reinsurance market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Life & Health Reinsurance market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Life & Health Reinsurance market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Life & Health Reinsurance include Munich Re, Swiss Re, Hannover Re, SCOR SE, Lloyd’s, Berkshire Hathaway, Great-West Lifeco, RGA and China RE, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Life & Health Reinsurance market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Life & Health Reinsurance.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Life & Health Reinsurance Market by Company
Munich Re
Swiss Re
Hannover Re
SCOR SE
Lloyd’s
Berkshire Hathaway
Great-West Lifeco
RGA
China RE
Korean Re
PartnerRe
GIC Re
Mapfre
Alleghany
Everest Re
Axa
Canada Life Reinsurance
Fairfax
AXIS
CCR Re
Sompo
The Toa Reinsurance Company
Life & Health Reinsurance Segment by Type
Proportional Reinsurance
Non-proportional Reinsurance
Life & Health Reinsurance Segment by Application
Children
Adults
Senior Citizens
Life & Health Reinsurance Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Life & Health Reinsurance market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Life & Health Reinsurance and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Life & Health Reinsurance.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Life & Health Reinsurance companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Proportional Reinsurance
- Non-proportional Reinsurance
Applications
- Children
- Adults
- Senior Citizens
Companies covered
- Munich Re
- Swiss Re
- Hannover Re
- SCOR SE
- Lloyd’s
- Berkshire Hathaway
- Great-West Lifeco
- RGA
- China RE
- Korean Re
- PartnerRe
- GIC Re
- Mapfre
- Alleghany
- Everest Re
- Axa
- Canada Life Reinsurance
- Fairfax
- AXIS
- CCR Re
- Sompo
- The Toa Reinsurance Company
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Life & Health Reinsurance by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Proportional Reinsurance
- 2.2.3 Non-proportional Reinsurance
- 2.3 Life & Health Reinsurance by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Children
- 2.3.3 Adults
- 2.3.4 Senior Citizens
- 2.4 Assumptions and Limitations
3 Life & Health Reinsurance Breakdown Data by Type
- 3.1 Global Life & Health Reinsurance Historic Market Size by Type (2021-2026)
- 3.2 Global Life & Health Reinsurance Forecasted Market Size by Type (2027-2032)
4 Life & Health Reinsurance Breakdown Data by Application
- 4.1 Global Life & Health Reinsurance Historic Market Size by Application (2021-2026)
- 4.2 Global Life & Health Reinsurance Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Life & Health Reinsurance Market Perspective (2021-2032)
- 5.2 Global Life & Health Reinsurance Growth Trends by Region
- 5.2.1 Global Life & Health Reinsurance Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Life & Health Reinsurance Historic Market Size by Region (2021-2026)
- 5.2.3 Life & Health Reinsurance Forecasted Market Size by Region (2027-2032)
- 5.3 Life & Health Reinsurance Market Dynamics
- 5.3.1 Life & Health Reinsurance Industry Trends
- 5.3.2 Life & Health Reinsurance Market Drivers
- 5.3.3 Life & Health Reinsurance Market Challenges
- 5.3.4 Life & Health Reinsurance Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Life & Health Reinsurance Players by Revenue
- 6.1.1 Global Top Life & Health Reinsurance Players by Revenue (2021-2026)
- 6.1.2 Global Life & Health Reinsurance Revenue Market Share by Players (2021-2026)
- 6.2 Global Life & Health Reinsurance Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Life & Health Reinsurance Head Office and Area Served
- 6.4 Global Life & Health Reinsurance Players, Product Type & Application
- 6.5 Global Life & Health Reinsurance Manufacturers Established Date
- 6.6 Global Life & Health Reinsurance Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Life & Health Reinsurance Market Size (2021-2032)
- 7.2 North America Life & Health Reinsurance Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Life & Health Reinsurance Market Size by Country (2021-2026)
- 7.4 North America Life & Health Reinsurance Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Life & Health Reinsurance Market Size (2021-2032)
- 8.2 Europe Life & Health Reinsurance Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Life & Health Reinsurance Market Size by Country (2021-2026)
- 8.4 Europe Life & Health Reinsurance Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Life & Health Reinsurance Market Size (2021-2032)
- 9.2 Asia-Pacific Life & Health Reinsurance Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Life & Health Reinsurance Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Life & Health Reinsurance Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Life & Health Reinsurance Market Size (2021-2032)
- 10.2 South America Life & Health Reinsurance Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Life & Health Reinsurance Market Size by Country (2021-2026)
- 10.4 South America Life & Health Reinsurance Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Life & Health Reinsurance Market Size (2021-2032)
- 11.2 Middle East & Africa Life & Health Reinsurance Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Life & Health Reinsurance Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Life & Health Reinsurance Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Munich Re
- 12.1.1 Munich Re Company Information
- 12.1.2 Munich Re Business Overview
- 12.1.3 Munich Re Revenue in Life & Health Reinsurance Business (2021-2026)
- 12.1.4 Munich Re Life & Health Reinsurance Product Portfolio
- 12.1.5 Munich Re Recent Developments
- 12.2 Swiss Re
- 12.2.1 Swiss Re Company Information
- 12.2.2 Swiss Re Business Overview
- 12.2.3 Swiss Re Revenue in Life & Health Reinsurance Business (2021-2026)
- 12.2.4 Swiss Re Life & Health Reinsurance Product Portfolio
- 12.2.5 Swiss Re Recent Developments
- 12.3 Hannover Re
- 12.3.1 Hannover Re Company Information
- 12.3.2 Hannover Re Business Overview
- 12.3.3 Hannover Re Revenue in Life & Health Reinsurance Business (2021-2026)
- 12.3.4 Hannover Re Life & Health Reinsurance Product Portfolio
- 12.3.5 Hannover Re Recent Developments
- 12.4 SCOR SE
- 12.4.1 SCOR SE Company Information
- 12.4.2 SCOR SE Business Overview
- 12.4.3 SCOR SE Revenue in Life & Health Reinsurance Business (2021-2026)
- 12.4.4 SCOR SE Life & Health Reinsurance Product Portfolio
- 12.4.5 SCOR SE Recent Developments
- 12.5 Lloyd’s
- 12.5.1 Lloyd’s Company Information
- 12.5.2 Lloyd’s Business Overview
- 12.5.3 Lloyd’s Revenue in Life & Health Reinsurance Business (2021-2026)
- 12.5.4 Lloyd’s Life & Health Reinsurance Product Portfolio
- 12.5.5 Lloyd’s Recent Developments
- 12.6 Berkshire Hathaway
- 12.6.1 Berkshire Hathaway Company Information
- 12.6.2 Berkshire Hathaway Business Overview
- 12.6.3 Berkshire Hathaway Revenue in Life & Health Reinsurance Business (2021-2026)
- 12.6.4 Berkshire Hathaway Life & Health Reinsurance Product Portfolio
- 12.6.5 Berkshire Hathaway Recent Developments
- 12.7 Great-West Lifeco
- 12.7.1 Great-West Lifeco Company Information
- 12.7.2 Great-West Lifeco Business Overview
- 12.7.3 Great-West Lifeco Revenue in Life & Health Reinsurance Business (2021-2026)
- 12.7.4 Great-West Lifeco Life & Health Reinsurance Product Portfolio
- 12.7.5 Great-West Lifeco Recent Developments
- 12.8 RGA
- 12.8.1 RGA Company Information
- 12.8.2 RGA Business Overview
- 12.8.3 RGA Revenue in Life & Health Reinsurance Business (2021-2026)
- 12.8.4 RGA Life & Health Reinsurance Product Portfolio
- 12.8.5 RGA Recent Developments
- 12.9 China RE
- 12.9.1 China RE Company Information
- 12.9.2 China RE Business Overview
- 12.9.3 China RE Revenue in Life & Health Reinsurance Business (2021-2026)
- 12.9.4 China RE Life & Health Reinsurance Product Portfolio
- 12.9.5 China RE Recent Developments
- 12.10 Korean Re
- 12.10.1 Korean Re Company Information
- 12.10.2 Korean Re Business Overview
- 12.10.3 Korean Re Revenue in Life & Health Reinsurance Business (2021-2026)
- 12.10.4 Korean Re Life & Health Reinsurance Product Portfolio
- 12.10.5 Korean Re Recent Developments
- 12.11 PartnerRe
- 12.11.1 PartnerRe Company Information
- 12.11.2 PartnerRe Business Overview
- 12.11.3 PartnerRe Revenue in Life & Health Reinsurance Business (2021-2026)
- 12.11.4 PartnerRe Life & Health Reinsurance Product Portfolio
- 12.11.5 PartnerRe Recent Developments
- 12.12 GIC Re
- 12.12.1 GIC Re Company Information
- 12.12.2 GIC Re Business Overview
- 12.12.3 GIC Re Revenue in Life & Health Reinsurance Business (2021-2026)
- 12.12.4 GIC Re Life & Health Reinsurance Product Portfolio
- 12.12.5 GIC Re Recent Developments
- 12.13 Mapfre
- 12.13.1 Mapfre Company Information
- 12.13.2 Mapfre Business Overview
- 12.13.3 Mapfre Revenue in Life & Health Reinsurance Business (2021-2026)
- 12.13.4 Mapfre Life & Health Reinsurance Product Portfolio
- 12.13.5 Mapfre Recent Developments
- 12.14 Alleghany
- 12.14.1 Alleghany Company Information
- 12.14.2 Alleghany Business Overview
- 12.14.3 Alleghany Revenue in Life & Health Reinsurance Business (2021-2026)
- 12.14.4 Alleghany Life & Health Reinsurance Product Portfolio
- 12.14.5 Alleghany Recent Developments
- 12.15 Everest Re
- 12.15.1 Everest Re Company Information
- 12.15.2 Everest Re Business Overview
- 12.15.3 Everest Re Revenue in Life & Health Reinsurance Business (2021-2026)
- 12.15.4 Everest Re Life & Health Reinsurance Product Portfolio
- 12.15.5 Everest Re Recent Developments
- 12.16 Axa
- 12.16.1 Axa Company Information
- 12.16.2 Axa Business Overview
- 12.16.3 Axa Revenue in Life & Health Reinsurance Business (2021-2026)
- 12.16.4 Axa Life & Health Reinsurance Product Portfolio
- 12.16.5 Axa Recent Developments
- 12.17 Canada Life Reinsurance
- 12.17.1 Canada Life Reinsurance Company Information
- 12.17.2 Canada Life Reinsurance Business Overview
- 12.17.3 Canada Life Reinsurance Revenue in Life & Health Reinsurance Business (2021-2026)
- 12.17.4 Canada Life Reinsurance Life & Health Reinsurance Product Portfolio
- 12.17.5 Canada Life Reinsurance Recent Developments
- 12.18 Fairfax
- 12.18.1 Fairfax Company Information
- 12.18.2 Fairfax Business Overview
- 12.18.3 Fairfax Revenue in Life & Health Reinsurance Business (2021-2026)
- 12.18.4 Fairfax Life & Health Reinsurance Product Portfolio
- 12.18.5 Fairfax Recent Developments
- 12.19 AXIS
- 12.19.1 AXIS Company Information
- 12.19.2 AXIS Business Overview
- 12.19.3 AXIS Revenue in Life & Health Reinsurance Business (2021-2026)
- 12.19.4 AXIS Life & Health Reinsurance Product Portfolio
- 12.19.5 AXIS Recent Developments
- 12.20 CCR Re
- 12.20.1 CCR Re Company Information
- 12.20.2 CCR Re Business Overview
- 12.20.3 CCR Re Revenue in Life & Health Reinsurance Business (2021-2026)
- 12.20.4 CCR Re Life & Health Reinsurance Product Portfolio
- 12.20.5 CCR Re Recent Developments
- 12.21 Sompo
- 12.21.1 Sompo Company Information
- 12.21.2 Sompo Business Overview
- 12.21.3 Sompo Revenue in Life & Health Reinsurance Business (2021-2026)
- 12.21.4 Sompo Life & Health Reinsurance Product Portfolio
- 12.21.5 Sompo Recent Developments
- 12.22 The Toa Reinsurance Company
- 12.22.1 The Toa Reinsurance Company Company Information
- 12.22.2 The Toa Reinsurance Company Business Overview
- 12.22.3 The Toa Reinsurance Company Revenue in Life & Health Reinsurance Business (2021-2026)
- 12.22.4 The Toa Reinsurance Company Life & Health Reinsurance Product Portfolio
- 12.22.5 The Toa Reinsurance Company Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst